Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroectodermal Tumors, Primitive × fludarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 65 Leukemia 62 Leukemia, Lymphocytic, Chronic, B-Cell 58 Myelodysplastic Syndromes 49 Lymphoma 42 Lymphoma, Non-Hodgkin 41 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Multiple Myeloma 36 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34 Hodgkin Disease 31 Melanoma 25 Hematologic Neoplasms 23 Myeloproliferative Disorders 15 Recurrence 14 Neoplasms 14 Neoplasm Metastasis 14 Lymphoma, Mantle-Cell 13 Lymphoma, Follicular 13 Primary Myelofibrosis 12 Lymphoma, Large B-Cell, Diffuse 12 Skin Neoplasms 11 Neoplasms, Plasma Cell 11 Graft vs Host Disease 10 Burkitt Lymphoma 10 Lymphoma, B-Cell, Marginal Zone 9 Anemia, Refractory, with Excess of Blasts 9 Lymphoma, B-Cell 8 Breast Neoplasms 8 Ovarian Neoplasms 7 Leukemia, Prolymphocytic 7

Interventions

antineoplaston AS 2-1 3 antineoplaston A10 3 dactolisib 2 Temozolomide 2 Irinotecan 2 Everolimus 2 Bevacizumab 2 spartalizumab 1 poly ICLC 1 plerixafor 1 pasireotide 1 fosbretabulin 1 cixutumumab 1 adavosertib 1 Vaccines 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation 1 PM 00104 1 Lapatinib 1 Immunologic Techniques 1 Immunoglobulin G 1 Genistein 1 Fentanyl 1 Donepezil 1 Disulfides 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡